A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

Condition:   Post Operative Pain Interventions:   Drug: F14;   Drug: 0.25 % Bupivacaine HCl;   Drug: Acetaminophen;   Drug: Methocarbamol Sponsors:   Arthritis Innovation Corporation;   Allucent Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials